Thank you for your interest in clinical trial participation at the Center for Vaccine Development and Global Health!
Clinical trials look at new ways to prevent, detect, or treat disease. Treatments might be new drugs or new combinations of drugs or new ways to use existing treatments. Each of our clinical trials are different. Clinical trials help determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses.
People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.
Please complete this contact form to be added to our list of potential participants and to receive our newsletter. We look forward to speaking with you about participation in a trial at the Center for Vaccine Development at the University of Maryland, Baltimore.
Healthy adults 18 to 50 years old are needed to participate in the study of an investigational antibody against malaria. The study will evaluate the safety of the malaria antibody and its ability to protect against malaria. Financial compensation will be provided.
Shigella vaccine study. Healthy adults 18 – 45 years. 2 outpatient vaccinations and a possible 12-day inpatient stay. Compensation up to $1175 - $3275. For more information, please call the Center for Vaccine Development: 410-706-7926.
The University of Maryland School of Medicine seeks participants for a pediatric nasal spray influenza vaccine study.
We are recruiting children aged 6 months through 17 years of age.
Your child’s participation can help CVD to develop the next generation of influenza vaccines that may protect longer and may prevent more infections than current vaccines.
Participants will receive up to $625 in compensation.
Are you interested in COVID-19 vaccine studies for your child or children? We have upcoming studies for children and adolescents in both Baltimore and Frederick, MD. Research studies have differing requirements for participation. Please fill out this form so that we can contact you when an applicable study is available.
Researchers at the University of Maryland School of Medicine are partnering with the public to better understand the spread of COVID-19. Study participants will complete short online questionnaires over several months about possible exposures to COVID-19, symptoms, and health care visits.
Ready to get started?
The purpose of the KidCOVE Study is to test a vaccine that may protect children from getting sick if they come into contact with SARS-CoV-2, which causes COVID-19.
In order to participate, your child must:
There are additional eligibility requirements, which the study doctor can explain to you.
This research study tests an investigational DNA vaccine for the Hantaan and Puumala viruses which are spread by exposure to rodents.